Scaffold marketed under HDE and a couple hydrogel product partners selling product
Most of us here have no doubts we will be at this point eventually. Anyone care to predict when the scaffold is selling under HDE and at least one hydrogel is in the market? And where will the stock price range it settles at?
Purely guessing but I think by Q1 2014 for when each are on market. Share price at least $7, IMO, and no downside with continual incremental increases
I still believe that behind the "scenes" that several major other players (?Johnson & Johnson etc.) are just waiting to see how the scaffold/hydrogel studies will turn out before they step in and offer to buy out In Vivo---I bet this will drive the stock into the +$15/pps if not more---whether Mr. Reynolds and the board of directors want to go this route--time will tell
I have poked around about this and I would say they keep the scaffold solo and take on a partner with hydrogel. The sales force is very small for scaffold because only 20 or so hospitals are trauma center that can do the procedure. The Hydrogel is a global product and they will probably need help with this because it can be used for so many markets. All.. huge upside and so much potential very soon.
No idea about actual stock price but I love this company for the multiple options. You have a free shot right now for scaffold and the insurance of Hydrogel coming soon. If you have any faith at all you would load up now and should have a 50% bump in the short term with major upside in 12months. I think it is very safe to assume plenty of press on this type of product when it goes live in humans.